questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of access to treatment for patients with BRAF-mutated bowel cancer in (a) England and (b) Northern Ireland.
answerText: The National Health Service in England is legally required to fund medicines in line with National Institute for Health and Care Excellence’s (NICE) recommendations. Current treatment options for BRAF-mutated colorectal cancer depend on the stage of the d...
heading: Bowel Cancer: Medical Treatments